Exciting new advances in glucagon delivery are right around the corner – injector pens, nasal sprays and mini-doses that can be self-administered.
read more →
Primary Care Providers are responsible for about 90% of all diabetes care in the U.S. – the reality being there simply aren’t enough diabetes specialists or endocrinologists to go around. Open and honest communication between patient and provider lays the groundwork for long-term success in diabetes management.
read more →
Dr. Edelman’s 90-year-old mom (the short one) wrote this article with her friend Soni, who was diagnosed with type 2 diabetes later in life. Getting type 2 and taking control of it gave Soni new energy, new clothes and a new flame!
read more →
The newest classes of diabetes meds to treat type 2 are pulling more than double duty, helping to better control blood sugars, protect the heart, lower body weight and prevent chronic kidney disease.
read more →Evidence-based hope is letting people know that things are different than they were even 20 years ago. We now know that that with well-managed type 1 or type 2 diabetes, the odds are good you’re going to live a long and healthy life.
read more →
SGLT-2 Inhibitors including Invokana (canagliflozin), Farxiga (dapagliflozin), Jardiance (empagliflozin) and Steglatro (ertugliflizin), are the newest class of oral medications for the treatment of type 2 diabetes. They’re generally well tolerated and associated with significant weight loss compared with other type 2 oral meds, but there are still precautions to consider.
read more →
The use of DPP-4 inhibitors (Januvia, Onglyza, Tradjenta and Nesina) has been so widespread because these medications come in a pill, only need to be taken once a day and have few side effects.
read more →
Insulin sensitizers represent an important class of oral medications for the treatment of type 2 diabetes and work mainly by reducing insulin resistance, but a false scare with rosiglitatone led to prescribing changes for many healthcare providers.
read more →
Metformin is currently recommended as the first drug of choice for people with newly diagnosed type 2 diabetes (unless there is a contraindication to it) and is generally a safe medication. However, there are a few precautions to take and things to be aware of while on the medication.
read more →
There are nine major types of oral medications in the U.S. for people living with type 2 diabetes. In this first article of a series, we’re focusing on sulfonylureas or SFUs, which are one of the oldest oral medications on the market.
read more →
